Avai Bio (AVAI) Accumulated Expenses (2018 - 2023)

Avai Bio has disclosed Accumulated Expenses across 6 years of filings, most recently posting $410000.0 for Q3 2023.

• In Q3 2023, Accumulated Expenses rose 157.05% year-over-year to $410000.0; the TTM figure through Sep 2023 stood at $410000.0 (up 157.05% YoY), while the FY2023 annual figure was $192600.0, up 0.84% from the prior year.
• Accumulated Expenses came in at $410000.0 for Q3 2023 at Avai Bio, down from $458600.0 in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $1.1 million in Q3 2020 to a low of $68135.0 in Q1 2019.
• Average Accumulated Expenses over 5 years is $325576.0, with a median of $220397.5 recorded in 2019.
• Year-over-year, Accumulated Expenses surged 1249.21% in 2019 and tumbled 79.12% in 2022.
• Over 5 years, Accumulated Expenses stood at $219795.0 in 2019, then advanced by 18.82% to $261161.0 in 2020, then slumped by 38.35% to $161000.0 in 2021, then rose by 17.7% to $189500.0 in 2022, then jumped by 116.36% to $410000.0 in 2023.
• Per Business Quant data, the three most recent Accumulated Expenses figures were $410000.0 in Q3 2023, $458600.0 in Q2 2023, and $192600.0 in Q1 2023.